sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Recruiting
Phase 3
Interventional Study
Post-COVID
POST-Covid 19
Post-COVID Conditions
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Fatigue, cognitive problems, post-exertional malaise (PEM) and postural orthostatic tachycardia syndrome (POTS) are common and debilitating symptoms after COVID-19. The pathophysiology of post-COVID is not well understood and there is no established biomedical treatment. Treatment options for post-COVID are thus much needed.
A promising candidate intervention is fluvoxamine, a selective serotonin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 to 70 years
* Severely fatigued (CIS fatigue score ≥ 35) at screening
* Fatigue started/increased significantly after Covid-19 (self-declared)
* Fatigue symptoms must be present for at least 3 months following the acute infection.
* Self-reported confirmation of…
Contacts
No contact information available.